Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2006

01-04-2006 | Inflammatory Bowel Disease

Increased Frequency of Mutations in the Gene Responsible for Familial Mediterranean Fever (MEFV) in a Cohort of Patients with Ulcerative Colitis: Evidence for a Potential Disease-Modifying Effect?

Authors: Stavros Giaglis, PhD, Konstantinos Mimidis, MD, Vassilios Papadopoulos, MD, Konstantinos Thomopoulos, MD, Prodromos Sidiropoulos, MD, Stavros Rafail, PhD, Vassiliki Nikolopoulou, MD, Eleni Fragouli, MD, Georgios Kartalis, MD, Athanasios Tzioufas, MD, Dimitrios Boumpas, MD, Konstantinos Ritis, MD

Published in: Digestive Diseases and Sciences | Issue 4/2006

Login to get access
Metadata
Title
Increased Frequency of Mutations in the Gene Responsible for Familial Mediterranean Fever (MEFV) in a Cohort of Patients with Ulcerative Colitis: Evidence for a Potential Disease-Modifying Effect?
Authors
Stavros Giaglis, PhD
Konstantinos Mimidis, MD
Vassilios Papadopoulos, MD
Konstantinos Thomopoulos, MD
Prodromos Sidiropoulos, MD
Stavros Rafail, PhD
Vassiliki Nikolopoulou, MD
Eleni Fragouli, MD
Georgios Kartalis, MD
Athanasios Tzioufas, MD
Dimitrios Boumpas, MD
Konstantinos Ritis, MD
Publication date
01-04-2006
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 4/2006
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-3192-1

Other articles of this Issue 4/2006

Digestive Diseases and Sciences 4/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine